Results 41 to 50 of about 73,008,320 (286)

Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling

open access: yesCells, 2020
The interleukin-22 (IL-22) signaling pathway is well known to be involved in the progression of various cancer types but its role in bone metastatic breast cancer remains unclear.
Eun-Young Kim   +5 more
doaj   +1 more source

The Role of T Helper 22 Cells in Dermatological Disorders

open access: yesFrontiers in Immunology, 2022
T helper 22 (Th22) cells are a newly identified subset of CD4+ T cells that secrete the effector cytokine interleukin 22 (IL-22) upon specific antigen stimulation, barely with IFN-γ or IL-17. Increasing studies have demonstrated that Th22 cells and IL-22
Yu Pan   +12 more
doaj   +1 more source

Research advances in understanding the role of interleukin-22 in renal disease

open access: yesLinchuang shenzangbing zazhi, 2022
Interleukin 22(IL-22),a member of IL-10 cytokine superfamily,is dominantly produced by innate lymphoid cells and CD4+ T helper subtypes such as Th17 and Th22 cells.And interleukin-22 receptor (IL-22R) is a dimer composed of IL-22R1 and IL-10R2 subunit.IL-
Zhao Dan   +7 more
doaj  

Interleukin-22 in the pathogenesis and potential treatment of liver diseases

open access: yesLiver Research, 2017
Interleukin (IL)-22, a member of the IL-10 cytokine family, plays critical roles in tissue repair and host defense. IL-22 binds to its hetereodimeric receptor (R) composed of IL-22R1 and IL-10R2 and activates downstream signaling, including Signal ...
Shi Yin, Dechun Feng
doaj   +1 more source

Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regeneration

open access: yesCell Reports Medicine, 2021
Summary: Necrotizing enterocolitis (NEC) is a deadly intestinal inflammatory disorder that primarily affects premature infants and lacks adequate therapeutics.
Belgacem Mihi   +18 more
doaj   +1 more source

Interleukin-22 (IL-22) Gingival Gene Expression and GCF Concentration in Periodontal Health and Disease

open access: yesInternational Journal of Dentistry and Oral Science, 2014
IL-22 is a cytokine that is assumed to improve anti-microbial defense of epidermal and epithelial cells and the cells of gas- trointestinal and respiratory systems. With respect to absence of enough relevant articles in this regard the aim of this study was to evaluate the correlation between IL-22 gene expression in gingival tissues as well as its ...
Amini Behbahani A   +3 more
openaire   +2 more sources

Serum Interleukin-22 in Iraqi Patients with Crohn’s Disease: Association with Biologic Treatment Status and Clinical Disease Activity

open access: yesمجلة الكوفة الطبية
Background: Interleukin-22 (IL-22) is an immunologically relevant cytokine in Crohn’s disease (CD), but its circulating clinical significance remains uncertain. This study evaluated serum IL-22 in Iraqi patients with CD and examined its association with
Ghaith Adnan Neamah   +1 more
doaj   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Interleukin-18 [PDF]

open access: yes, 2003
Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses.
McInnes, I.B.   +2 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy